LM
VNRX icon

Luminus Management’s VolitionRx Ltd VNRX Stock Holding History

Luminus Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
156,897
+107,147
+215% +$258K 0.14% 26
2026
Q1 		$201K Buy
+49,750
New +$238K 0.12% 24

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Luminus Management's VNRX Position: Q2 2026 in Review

Luminus Management increased its VolitionRx Ltd (VNRX) stake by 215% in Q2 2026, buying an estimated $258K and bringing the position to 156,897 shares worth $212K. The position accounts for 0.14% of the portfolio, ranked #26.

Luminus Management first reported a position in VNRX in Q1 2026 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Luminus Management held 156,897 shares of VolitionRx Ltd worth $212K as of Q2 2026.
  • Luminus Management bought 107,147 VolitionRx Ltd shares in Q2 2026, an estimated $258K.
  • VolitionRx Ltd made up 0.14% of Luminus Management's portfolio in Q2 2026, its #26 holding.
  • Luminus Management first reported a position in VolitionRx Ltd in Q1 2026 and has held it in 2 quarters since.
  • 25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Luminus Management's 13F filing for Q2 2026, filed 14 Aug 2026.